HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adiponectin attenuates neuronal apoptosis induced by hypoxia-ischemia via the activation of AdipoR1/APPL1/LKB1/AMPK pathway in neonatal rats.

Abstract
Adiponectin is an important adipocyte-derived plasma protein that has beneficial effects on cardio- and cerebrovascular diseases. A low level of plasma Adiponectin is associated with increased mortality post ischemic stroke; however, little is known about the causal role of Adiponectin as well as its molecular mechanisms in neonatal hypoxia ischemia (HI). In the present study, ten-day-old rat pups were subjected to right common carotid artery ligation followed by 2.5 h hypoxia. Recombinant human Adiponectin (rh-Adiponectin) was administered intranasally 1 h post HI. Adiponectin Receptor 1 (AdipoR1) siRNA, APPL1 siRNA, LKB1 siRNA were administered through intracerebroventricular injection 48 h before HI. Brain infarct area measurement, neurological function test, western blot, Fluoro Jade C (FJC), TUNEL, and immunofluorescence staining were conducted. Results revealed that endogenous Adiponectin, AdipoR1 and APPL1 were increased in a time dependent manner after HI. Administration of rh-Adiponectin reduced brain infarct area, neuronal apoptosis, brain atrophy and improved neurological function at 24 h and 4 weeks post HI. Furthermore, rh-Adiponectin treatment increased Adiponectin, AdipoR1, APPL1, cytosolic LKB1, p-AMPK expression levels and thereby attenuated apoptosis as shown by the decreased expression of the pro-apoptotic marker, Cleaved Caspase 3 (C-Cas3), as well as the number of FJC and TUNEL positively stained neurons. AdipoR1, APPL1 and LKB1 siRNAs abolished the anti-apoptotic effects of rh-Adiponectin at 24 h after HI. Collectively, the data provided evidence that intranasal administration of rh-Adiponectin attenuated neuronal apoptosis at least in part via activating AdipoR1/APPL1/LKB1/AMPK signaling pathway. Adiponectin could represent a therapeutic target for treatment of neonatal hypoxic ischemic encephalopathy.
AuthorsNingbo Xu, Yixin Zhang, Desislava Met Doycheva, Yan Ding, Yiting Zhang, Jiping Tang, Hongbo Guo, John H Zhang
JournalNeuropharmacology (Neuropharmacology) Vol. 133 Pg. 415-428 (05 01 2018) ISSN: 1873-7064 [Electronic] England
PMID29486166 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier Ltd. All rights reserved.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Adiponectin
  • Appl1 protein, rat
  • Fluoresceins
  • Nerve Tissue Proteins
  • RNA, Small Interfering
  • Receptors, Adiponectin
  • adiponectin receptor 1, rat
  • fluoro-jade C
  • Protein Kinases
  • Protein Serine-Threonine Kinases
  • Stk11 protein, rat
  • AMP-Activated Protein Kinase Kinases
  • Caspase 3
Topics
  • AMP-Activated Protein Kinase Kinases
  • Adaptor Proteins, Signal Transducing (genetics, metabolism)
  • Adiponectin (therapeutic use)
  • Animals
  • Animals, Newborn
  • Apoptosis (drug effects)
  • Body Weight (drug effects)
  • Brain Infarction (drug therapy, etiology)
  • Caspase 3 (metabolism)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Escape Reaction (drug effects)
  • Female
  • Fluoresceins (metabolism)
  • Gene Expression Regulation (drug effects, genetics)
  • Hypoxia-Ischemia, Brain (drug therapy, pathology)
  • In Situ Nick-End Labeling
  • Male
  • Nerve Tissue Proteins (genetics, metabolism)
  • Neurologic Examination
  • Neurons (drug effects)
  • Protein Kinases (genetics, metabolism)
  • Protein Serine-Threonine Kinases (genetics, metabolism)
  • RNA, Small Interfering (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adiponectin (genetics, metabolism)
  • Reflex (drug effects)
  • Signal Transduction (drug effects, genetics)
  • Statistics, Nonparametric
  • Swimming (physiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: